关于扩大证据基础以指导疫苗引入的观点：项目成本核算与成本效益分析。 - Suppr | 超能文献

Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses.

作者信息

Andrus Jon Kim, Walker Damian G

机构信息

Sabin Vaccine Institute, 2000 Pennsylvania Avenue, NW Suite 7100, Washington, DC 20006, USA.

Bill and Melinda Gates Foundation, 500 Fifth Avenue, North Seattle, WA 98109, USA.

出版信息

Vaccine. 2015 May 7;33 Suppl 1:A2-3. doi: 10.1016/j.vaccine.2015.01.001.

DOI:10.1016/j.vaccine.2015.01.001

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses.关于扩大证据基础以指导疫苗引入的观点：项目成本核算与成本效益分析。

Vaccine. 2015 May 7;33 Suppl 1:A2-3. doi: 10.1016/j.vaccine.2015.01.001.

2

Foreword.前言。

Vaccine. 2015 May 7;33 Suppl 1:A1. doi: 10.1016/j.vaccine.2015.02.001.

3

Perspectives on the development and use of economic evidence for immunization decision-making in a developing country.发展中国家免疫接种决策中经济证据的开发与应用展望

Vaccine. 2015 May 7;33 Suppl 1:A6-7. doi: 10.1016/j.vaccine.2014.12.048.

4

The ProVac initiative and evolving decision support.ProVac计划与不断发展的决策支持

Vaccine. 2015 May 7;33 Suppl 1:A8-10. doi: 10.1016/j.vaccine.2014.12.049.

5

Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes.全球疫苗免疫联盟的平衡之举：加速疫苗获取，同时确保国家为可持续项目做出有力决策。

Vaccine. 2015 May 7;33 Suppl 1:A4-5. doi: 10.1016/j.vaccine.2014.12.051.

6

ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.全球ProVac倡议：由十年支持基于证据的政策决策所塑造的愿景。

Vaccine. 2015 May 7;33 Suppl 1:A21-7. doi: 10.1016/j.vaccine.2014.12.080.

7

Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.通过建设经济评估能力加强国家免疫决策：在欧洲实施ProVac项目

Vaccine. 2015 May 7;33 Suppl 1:A34-9. doi: 10.1016/j.vaccine.2014.12.073.

8

Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.疫苗引入的循证决策：ProVac国际工作组经验概述

Vaccine. 2015 May 7;33 Suppl 1(0 1):A28-33. doi: 10.1016/j.vaccine.2014.10.090.

9

The role of health economic analyses in vaccine decision making.健康经济分析在疫苗决策中的作用。

Vaccine. 2013 Dec 9;31(51):6046-9. doi: 10.1016/j.vaccine.2013.08.008. Epub 2013 Aug 20.

10

What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?我们从全球疫苗免疫联盟（GAVI）资助国家的综合性多年计划中学到了关于常规免疫接种成本和融资的哪些内容？

Vaccine. 2015 May 7;33 Suppl 1:A93-8. doi: 10.1016/j.vaccine.2014.12.076.

引用本文的文献

1

Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries.乙型肝炎病毒检测与治疗策略的经济学评估及其在低收入和中等收入国家的适用性

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):692. doi: 10.1186/s12879-017-2778-x.